TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis

  title={TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis},
  author={D. Jiang and L. Yao and Wei-hua Ren and W. Wang and B. Peng and L. Yu},
  journal={Medical Oncology},
  • D. Jiang, L. Yao, +3 authors L. Yu
  • Published 2011
  • Medicine
  • Medical Oncology
  • Studies investigating the relationship between TP53 Arg72Pro polymorphism and endometrial cancer risk reported conflicting results. To explore a more precise estimate of the effect of this polymorphism on endometrial carcinogenesis, a meta-analysis was performed by searching eligible studies in PubMed. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the association for codominant model (Arg/Arg vs. Pro/Pro, Arg/Pro vs. Pro/Pro), dominant model (Arg/Arg + Arg/Pro… CONTINUE READING
    11 Citations
    Polymorphism of p53 gene codon 72 in endometrial cancer: correlation with tumor grade and histological type.
    • 9
    • PDF
    Risk factors for endometrial cancer: An umbrella review of the literature
    • 40
    • PDF
    The prognostic value of miR-21 and miR-155 in non-small-cell lung cancer: a meta-analysis.
    • Yan Wang, Jinyuan Li, +5 authors M. Chu
    • Medicine
    • Japanese journal of clinical oncology
    • 2013
    • 46
    • PDF
    The Expression Levels of XLF and Mutant P53 Are Inversely Correlated in Head and Neck Cancer Cells
    • 5
    • PDF


    P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case–control studies
    • 43
    P53 codon 72 polymorphism and gastric cancer: A meta‐analysis of the literature
    • 135
    The p53 Codon 72 Exon 4 BstUI Polymorphism and Endometrial Cancer in Caucasian Women
    • 20
    Germline polymorphism of p53 codon 72 in gynecological cancer.
    • 46
    P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case–control studies
    • 65
    p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.
    • 67
    TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies.
    • 133
    Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer.
    • 55
    Polymorphisms of p53 codon 72 and MDM2 promoter 309 and the risk of endometrial cancer
    • 32